In the experimental animal model of AF, fenofibrate was found to decrease metabolic remodeling by regulating the PPAR-α/sirtuin 1/PGC-1α pathway and reversed shortened atrial refractory period [104]. The gene discussed is PPARGC1A; the disease is atrial fibrillation.